In today’s recent session, 3.35 million shares of the Allarity Therapeutics Inc (NASDAQ:ALLR) have been traded, and its beta is 0.47. Most recently the company’s share price was $0.67, and it changed around -$0.12 or -15.04% from the last close, which brings the market valuation of the company to $1.60M. ALLR at last check was trading at a discount to its 52-week high of $315.92, offering almost -47052.24% off that amount. The share price’s 52-week low was $0.71, which indicates that the recent value has fallen by an impressive -5.97% since then. We note from Allarity Therapeutics Inc’s average daily trading volume that its 3-month average coming to 3.14 million.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Instantly ALLR has been showing red trend so far today with a performance of -15.04% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently down -93.92% year-to-date, but still down -12.63% over the last five days. On the other hand, Allarity Therapeutics Inc (NASDAQ:ALLR) is -60.12% down in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Allarity Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -93.02 percent over the past six months and at a 98.73% annual growth rate that is well above the industry average of 13.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 99.90% in revenue this quarter, and will report an increase of 99.40% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 57.56%.
